IDVSmall business
FSS (multiple-award IDV) 36F79722D0182IMPEL PHARMACEUTICALS INC
Overview
Award facts
- Obligated on orders under this IDV
- $11.11K
- $11,105 across 4 orders
- Period of performance
- From Aug 15, 2022
- Modifications
- 4
- Latest action Jan 8, 2025
- Contract type
- FSS (multiple-award IDV)
- PIID 36F79722D0182
Description of requirement
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Dates and value
- Award date
- Signed on Jul 19, 2022
- Ordering period ends
- Aug 14, 2027
- Ceiling
- Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $5,200,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 8, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationSEATTLE, WA
UEIVGX8L65CX5A3
CAGE code55Y39
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyIMPEL PHARMACEUTICALS INC
Business types and certifications
For-profit organizationCorporation (not tax-exempt)Manufacturer of goods
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Veterans Affairs
- NAC FEDERAL SUPPLY SCHEDULE (36F797)
- Funded by
- Department of Veterans Affairs
- NAC FEDERAL SUPPLY SCHEDULE (36F797)
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Fixed price with economic price adjustmentK
Solicitation and notices
- Solicitation ID
- M5-Q50A-03-R8(as reported)
- Solicitation date
- Jun 21, 2018
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
Transaction history
Modification history
- Base award
- Jul 19, 2022
- Latest action
- Jan 8, 2025 — Supplemental agreement (within scope)Modification P00004
- Latest substantive action
- Jan 8, 2025 — Supplemental agreement (within scope)Modification P00004
- Actions by type
- Base award1
- Supplemental agreement (within scope)4
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- FSSC
- Multiple or single award
- Multiple awardM
- Awarding agency code
- 3600
- Awarding sub-tier code
- 3600
- Contracting office code
- 36F797
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 3600
- Funding sub-tier code
- 3600
- Funding office code
- 36F797